STRONGBRIDGE BIOPHARMA plc Earnings Per Share (Diluted)
STRONGBRIDGE BIOPHARMA plc reported Earnings Per Share (Diluted) of -$0.21 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for the quarter ending 2021-06-30 was -$0.21.
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for the quarter ending 2021-03-31 was -$0.18.
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for the quarter ending 2020-12-31 was -$0.18.
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for the quarter ending 2020-09-30 was -$0.18.
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for fiscal 2020 was -$0.78.
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for fiscal 2019 was -$1.10, a 454.84% decline from fiscal 2018.
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for fiscal 2018 was $0.31.
- STRONGBRIDGE BIOPHARMA plc earnings per share, diluted for fiscal 2017 was -$3.11.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$0.21 10-Q · filed 2021-08-05 | -$0.37 10-Q · filed 2021-08-05 | -$0.56 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2021-08-05 |
| 2021-03-31 | -$0.18 10-Q · filed 2021-05-12 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$0.53 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$0.83 derived: net income ÷ weighted average shares · filed 2021-08-05 |
| 2020-12-31 | -$0.18 10-K · filed 2021-03-03 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-03-03 | -$0.66 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$0.78 10-K · filed 2021-03-03 |
| 2020-09-30 | -$0.18 10-K · filed 2021-03-03 | -$0.49 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$0.60 10-Q · filed 2020-10-29 | -$0.93 derived: net income ÷ weighted average shares · filed 2021-08-05 |
| 2020-06-30 | -$0.32 10-Q · filed 2021-08-05 | -$0.55 10-Q · filed 2021-08-05 | -$0.75 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$1.06 derived: net income ÷ weighted average shares · filed 2021-08-05 |
| 2020-03-31 | -$0.24 10-Q · filed 2021-05-12 | -$0.43 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$0.75 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$1.05 derived: net income ÷ weighted average shares · filed 2021-05-12 |
| 2019-12-31 | -$0.17 10-K · filed 2020-02-28 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-03-03 | -$0.81 derived: net income ÷ weighted average shares · filed 2021-03-03 | -$1.10 10-K · filed 2021-03-03 |
| 2019-09-30 | -$0.31 10-Q · filed 2020-10-29 | -$0.62 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$0.91 10-Q · filed 2020-10-29 | $0.60 derived: net income ÷ weighted average shares · filed 2021-03-03 |
| 2019-06-30 | -$0.30 10-Q · filed 2020-08-04 | -$0.60 10-Q · filed 2020-08-04 | $0.92 derived: net income ÷ weighted average shares · filed 2021-03-03 | $0.40 derived: net income ÷ weighted average shares · filed 2021-03-03 |
| 2019-03-31 | -$0.34 10-Q · filed 2020-05-06 | $1.28 derived: net income ÷ weighted average shares · filed 2021-03-03 | $0.74 derived: net income ÷ weighted average shares · filed 2021-03-03 | $0.32 derived: net income ÷ weighted average shares · filed 2021-03-03 |
| 2018-12-31 | $1.64 10-K · filed 2020-02-28 | $1.14 derived: net income ÷ weighted average shares · filed 2021-03-03 | $0.69 derived: net income ÷ weighted average shares · filed 2021-03-03 | $0.31 10-K · filed 2021-03-03 |
| 2018-09-30 | -$0.55 10-K · filed 2020-02-28 | -$0.99 derived: net income ÷ weighted average shares · filed 2019-11-07 | -$1.37 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$0.43 10-K · filed 2020-02-28 | -$0.81 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | -$0.66 10-K · filed 2020-02-28 | |||
| 2017-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2020-02-28 | -$1.43 derived: net income ÷ weighted average shares · filed 2020-02-28 | -$2.27 derived: net income ÷ weighted average shares · filed 2020-02-28 | -$3.11 10-K · filed 2020-02-28 |
| 2017-09-30 | -$0.98 10-Q · filed 2018-10-31 | -$1.84 derived: net income ÷ weighted average shares · filed 2018-10-31 | -$2.67 10-Q · filed 2018-10-31 | |
| 2017-06-30 | -$0.86 10-Q · filed 2018-08-08 | -$1.69 10-Q · filed 2018-08-08 | ||
| 2016-12-31 | -$0.73 10-K · filed 2018-03-12 | -$2.27 10-K · filed 2019-02-27 | ||
| 2016-09-30 | -$0.36 10-K · filed 2018-03-12 | |||
| 2016-06-30 | -$0.61 10-K · filed 2018-03-12 | |||
| 2016-03-31 | -$0.57 10-K · filed 2018-03-12 | |||
| 2015-12-31 | -$2.62 10-K · filed 2018-03-12 | |||
| 2014-12-31 | -$1.20 20-F · filed 2017-04-04 |